Evidence map›Paper›PMID 40980602›Full record

ReviewIJID regions2025

Standardizing Vulvovaginal candidiasis diagnosis in Uganda: A case for British Association for Sexual Health and HIV 2019 guidelines.

Bwambale Jonani

Abstract readReview
In one paragraph

Review in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bwambale JonaniDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulvovaginal candidiasis (VVC) significantly affects women's health in Uganda, with an annual economic burden of 280.77 billion Ugandan Shillings (US$75,696 annually), which is 11.22% of health spending. Current clinical practices predominantly rely on syndromic management or, where available, Sabouraud Dextrose Agar cultures, which cannot distinguish between colonization and active infection, leading to misdiagnosis and inappropriate antifungal use. The 2019 British Association for Sexual Health and HIV guidelines offer a structured diagnostic framework that integrates clinical assessment, microscopy, and targeted culture techniques. This review proposes implementing these guidelines within Uganda's laboratory hub network to improve diagnostic accuracy and antifungal stewardship.

Indexed as

DiagnosisPrevalenceUgandaVulvovaginal candidiasis

Identifiers

PMID40980602
PMCPMC12445571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.